Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03146117 · ClinicalTrials.gov registry record

PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer

A clinical trial, sponsored by Medical University of South Carolina.

Terminated
Registry status
25
Enrollment target

NCT03146117 is a clinical trial that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03146117 was terminated before completion, sponsored by Medical University of South Carolina.

TERMINATED
Registry status
25 participants
Enrollment target

Study Summary

The overall goal of this project is to investigate the diagnostic performance of integrated F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) and Dual Energy CT (DECT) imaging in determining the thoracic nodal status of small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC), and its impact on target volume delineation for image guided radiation therapy (IGRT) planning.

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2017-04-01
Est. Completion 2018-06-15

What the Registry Record Tells You About NCT03146117

The ClinicalTrials.gov registry entry for NCT03146117 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03146117 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03146117 about?

NCT03146117 is a clinical study titled "PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer". The overall goal of this project is to investigate the diagnostic performance of integrated F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) and Dual Energy CT (DECT) imaging in determining the thoracic nodal status of small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC...

What is the current status of trial NCT03146117?

This trial is currently terminated. The enrollment target is 25 participants. The study started on 2017-04-01. Estimated completion is 2018-06-15.

Who is sponsoring clinical trial NCT03146117?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.